NRGEX | SMAYX | NRGEX / SMAYX | |
Total Expense Ratio | 0.03 | 0.98 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 0.98 | 70% |
Fund Existence | 4 years | 10 years | - |
Gain YTD | -3.342 | 4.744 | -70% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.69B | 294M | 2,954% |
Annual Yield % from dividends | 0.54 | 0.30 | 179% |
Returns for 1 year | -9.46 | -2.53 | 374% |
Returns for 3 years | 8.17 | 31.58 | 26% |
Returns for 5 years | N/A | 6.92 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 75.60 | 0.47 | +0.63% |
Janus Henderson Global Life Sciences N | |||
GMCUX | 16.77 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R6 | |||
RLEFX | 38.98 | 0.04 | +0.10% |
American Funds American Balanced R5E | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst | |||
TAISX | 13.83 | -0.09 | -0.65% |
Nuveen Quant Intl Small Cap Eq I |